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24 exons spanning 140 kb; 4.2 kb cDNA. 
Protein 
Description 




Possibly membrane associated. 
Function 
Tyrosine kinase; associates with the intracellular 
domains of cytokine receptors; signal transduction. 
Homology 
>90% identical to the mouse and the rat JAK2 
homologs; belongs to the janus kinase subfamilly 















5' ETV6 - 3' JAK2. 
Abnormal Protein 
N-term- HLH from ETV6 fused to the the tyrosine 
Kinase c-term domains of JAK2. 
Oncogenesis 
It may be speculated that the HLH domain of ETV6 
provides a dimerization interface to the kinase domain 
of JAK2, which activates JAK2. 
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